Table 2.
Outcomes
Historical controls (n = 215) |
Consulted admissions (n = 215) |
p-value | Odds ratio (CI) unadjusted | Odds ratio (CI) adjusted* | |
---|---|---|---|---|---|
New inpatient treatment | 2 (0.9%) | 71 (33.0%) | <0.001 | 52.5 (12.6–218.6) | 49.8 (12.4–200.3) |
New MAUD at discharge | 4 (1.9%) | 89 (41.4%) | <0.001 | 37.3 (13.3–104.6) | 36.3 (12.6–104.8) |
Patient-directed discharge | 34 (15.8%) | 31 (14.4%) | 0.67 | 0.9 (0.5–1.6) | 0.9 (0.5–1.6) |
Historical controls (n = 215) |
Consulted admissions (n = 215) |
p-value | Hazard ratio (CI) unadjusted | Hazard ratio (CI) adjusted* | |
30-day readmission | 51 (23.7%) | 54 (25.1%) | 0.74 | 1.1 (0.7–1.7) | 1.2 (0.7–1.8) |
7-day readmission | 9 (4.2%) | 14 (6.5%) | 0.28 | 1.6 (0.7–3.7) | 1.8 (0.8–4.3) |
30-day ER visit | 74 (34.4%) | 72 (33.5%) | 0.84 | 1.0 (0.7–1.5) | 1.0 (0.7–1.6) |
7-day ER visit | 23 (10.7%) | 28 (13.0%) | 0.46 | 1.2 (0.7–2.2) | 1.5 (0.8–2.6) |
*Adjusted for race/ethnicity, blood alcohol concentration, maximum AST value, maximum creatinine value, and ICU admission